1P-LSD, or 1-Propionyl-lysergic acid diethylamide, is a semi-synthetic psychedelic compound closely related to LSD-25. It is classified as a lysergamide and is considered a prodrug, meaning it metabolizes into LSD in the body after ingestion. 1P-LSD has gained popularity among researchers and psychonauts for its legal availability in certain jurisdictions and its near-identical effects to traditional LSD. Though not approved for medical use, it is commonly used for personal research, microdosing, and introspective exploration.

• Chemical Structure
  1P-LSD is a structural analog of LSD with a propionyl group attached to the nitrogen molecule. This modification doesn’t change its core psychoactive profile but makes it a distinct compound for legal and research classification.

• Prodrug Conversion
  Upon ingestion, 1P-LSD is rapidly hydrolyzed by the body’s enzymes, converting it into active LSD-25. This means its effects are essentially the same as LSD, though some users report a slightly delayed onset.

• Psychoactive Classification
  Like LSD, 1P-LSD is a serotonergic psychedelic, primarily acting on the 5-HT2A receptor in the brain. This receptor is associated with mood, perception, cognition, and consciousness.

• Research Use Only
  While many users consume 1P-LSD recreationally, vendors like us at Psycho Plug sell it strictly for research purposes. It is labeled accordingly, and buyers are responsible for its use.

• Popularity and Appeal
  1P-LSD is especially favored in countries where LSD is banned but 1P-LSD falls outside of controlled substance regulations. This makes it a legal alternative in certain regions, depending on local law.

• Visual and Cognitive Effects
  Users often report vivid visuals, altered sense of time, heightened introspection, and cognitive fluidity. These effects are consistent with LSD, making it an ideal substitute.

The legal status of 1P-LSD depends entirely on local, regional, and national drug laws. It is often classified differently from LSD because of its slight structural variation. In some countries, this distinction keeps 1P-LSD legal or unregulated, while in others, analog laws or specific listings may prohibit its possession, sale, or use. It is the buyer’s responsibility to research and understand the laws in their jurisdiction before placing an order.

• Uncontrolled in Some Regions
  In countries without blanket analog laws, such as certain parts of Europe, 1P-LSD may not be explicitly banned and is often sold as a legal research chemical.

• Controlled by Analog Laws
  In the United States, the Federal Analogue Act may consider 1P-LSD illegal if it’s intended for human consumption, due to its structural similarity to LSD.

• Legal Loopholes for Research
  Some jurisdictions permit the purchase and possession of 1P-LSD strictly for scientific or research purposes, provided it’s not used as a recreational drug.

• Customs and Import Risks
  Even in countries where 1P-LSD is not classified, customs agents may detain shipments based on suspicion. We ship discreetly to minimize these risks, but legality remains a factor.

• Dynamic Legal Landscape
  Laws concerning novel psychedelics are rapidly evolving. What is legal today may be restricted tomorrow, so customers should stay updated on changes to national drug policies.

• Responsibility Disclaimer
  At Psycho Plug, we clearly label all our products as “not for human consumption” and encourage buyers to ensure they are complying with local regulations before purchasing.

1P-LSD produces psychedelic effects nearly identical to LSD-25 due to its metabolic conversion in the body. These effects are primarily psychological, emotional, and sensory, and they vary in intensity depending on dose, setting, and user sensitivity. Most users experience a combination of visual distortions, time dilation, emotional shifts, and altered thought patterns.

• Visual Enhancements
  Users often report vivid geometric patterns, enhanced color perception, light trails, and movement in static objects. These visuals may occur with eyes open or closed.

• Altered Time Perception
  Time can appear to slow down or speed up dramatically. A 10-minute period may feel like an hour, and this distortion can lead to profound reflection or disorientation.

• Emotional Intensification
  Emotions become amplified, whether positive or negative. This can result in euphoria, laughter, empathy, or emotional breakthroughs, but also anxiety or confusion if the environment is not supportive.

• Increased Sensory Awareness
  Smells, sounds, and touch sensations may become more pronounced. Music often feels deeper or more emotionally moving.

• Cognitive Shifts
  Thought loops, philosophical insights, and introspective realizations are common. Users often describe accessing new perspectives or confronting deeply buried emotions.

• Ego Dissolution (High Doses)
  At higher doses, users may experience ego death or a loss of self-identity, often described as merging with the universe or observing one’s consciousness from a third-person perspective.

Although 1P-LSD and LSD share a nearly identical experience, there are key differences at the chemical and legal levels. 1P-LSD is considered a prodrug for LSD, meaning it becomes LSD in the body after ingestion. This transformation explains why their effects are so similar, yet their regulatory classification and pharmacokinetics can differ.

• Legal Classification
  LSD is a well-known controlled substance in most countries. 1P-LSD, due to its unique chemical structure, often remains legal or unscheduled in places where LSD is banned.

• Onset and Duration
  1P-LSD generally has a slightly delayed onset (45–90 minutes) compared to LSD’s 30–60 minutes. However, overall duration and intensity are nearly identical.

• Molecular Structure
  The addition of a propionyl group in 1P-LSD makes it distinct under the law, even though that group is cleaved off metabolically to yield LSD.

• Stability and Storage
  1P-LSD is often more chemically stable than LSD, giving it a longer shelf life and better resistance to degradation from heat and light.

• Subjective Experience
  Some users claim subtle differences in mental clarity, body load, or emotional tone, although these are typically negligible for most people.

• Lab Classification
  1P-LSD is frequently used in lab research and analytical testing as a legal substitute for LSD in countries where strict controls exist.

Dosing 1P-LSD depends on a variety of factors including body weight, individual tolerance, sensitivity, and desired outcome (microdosing, moderate trip, or intense journey). Like LSD, it’s active at extremely low doses, making accurate measurement and caution essential. Users are strongly advised to begin with a low dose, especially when unfamiliar with the substance.

• Threshold Dose
  Around 25µg to 40µg is typically the minimum at which effects can be perceived. This may include slight mood shifts or sensory sharpening.

• Standard Dose (1 Tab)
  The standard psychoactive dose is 100µg, which typically delivers a full psychedelic experience including visuals, altered cognition, and emotional depth.

• High Dose Range
  Doses above 150–200µg can lead to intense trips with deeper ego dissolution, stronger visuals, and more pronounced time distortion. Not recommended for beginners.

• Microdosing
  5–15µg every 3–4 days is the standard microdosing protocol. This produces sub-perceptual effects intended to enhance mood, creativity, and productivity without hallucinations.

• Titration Strategy
  New users are advised to start with half a tab (50µg) to assess sensitivity. Effects vary widely between individuals.

• Measurement Caution
  Especially with liquid or powder, precise dosing tools such as micropipettes or digital milligram scales are essential. Overdosing is unlikely to be fatal but can cause extreme psychological distress.

The duration of 1P-LSD closely mirrors that of traditional LSD-25, generally lasting between 8 to 12 hours depending on the dose and individual metabolism. The onset tends to be slightly delayed compared to LSD, but once it activates, the trip follows a familiar arc of peak intensity, plateau, and gradual return to baseline. Users should plan for a full day of recovery time, especially with moderate to high doses.

• Onset Phase (45–90 minutes)
  After ingestion, effects typically begin within 45 to 90 minutes. This phase may include early sensory sensitivity, shifting colors, and light euphoria.

• Peak Experience (3–6 hours)
  The peak is where the most intense effects occur—visuals, altered time perception, deep introspection, and emotional flooding. Time may feel suspended, and thoughts may loop or fragment.

• Plateau (1–2 hours)
  After the peak, effects begin to level off. Users often experience sustained visuals with more mental clarity and emotional calmness compared to the peak.

• Comedown Phase (2–4 hours)
  As effects subside, mental and physical fatigue may set in. This phase often includes reflection, lingering visual artifacts, and mild overstimulation.

• Afterglow (12–24 hours post-trip)
  Many report a “glow” the day after, marked by enhanced emotional balance, mood elevation, and creative inspiration. Others may experience difficulty sleeping.

• Total Duration (8–12 hours)
  Depending on dose and tolerance, the entire experience can last up to 12 hours, with residual stimulation extending beyond that for some users.

Yes, 1P-LSD is widely used as a microdosing agent due to its structural similarity to LSD and consistent potency. Microdosing involves taking sub-perceptual doses—amounts too small to cause noticeable psychedelic effects but sufficient to promote cognitive, emotional, or physiological benefits. Many users turn to 1P-LSD when LSD is unavailable or restricted in their region.

• Typical Microdose Range
  Common microdoses range from 5µg to 15µg, taken every third day or according to a tailored protocol. At this level, users should not feel high or impaired.

• Cognitive Benefits
  Reported improvements include enhanced focus, creative thinking, verbal fluency, and task switching—making it popular among professionals and artists.

• Mood Stabilization
  Many users note better emotional regulation, reduced anxiety, and relief from symptoms of depression over consistent use.

• Physical Sensitivity
  While visual hallucinations are not expected, users may experience increased body awareness, subtle energy changes, or mild stimulation.

• Low Tolerance Accumulation
  Tolerance still builds with microdosing, so cycling is recommended (e.g., 4 weeks on, 2 weeks off) to preserve effectiveness.

• Ideal for Sensitive Users
  Individuals who are anxious about full psychedelic experiences may find microdosing a gentle, manageable entry point into the benefits of psychedelics.

• Liquid Form Preferred
  1P-LSD in liquid solution offers better microdosing precision. Droppers with calibrated concentrations make it easier to control sub-threshold doses accurately.

While no substance is entirely without risk, 1P-LSD is considered physiologically safe at responsible doses. It shares the low toxicity profile of LSD, with no documented cases of fatal overdose. However, psychological risks must be considered—particularly with higher doses or in unsupervised, unstable environments.

• Non-Toxic at Normal Doses
  1P-LSD does not harm organs, cause cellular damage, or result in physiological dependency. It is nontoxic even at doses several times higher than average.

• No Known Fatal Overdoses
  As with LSD, there are no verified cases of 1P-LSD causing death from overdose. Physical harm from the substance itself is unlikely.

• Psychological Safety Depends on Setting
  A bad trip or emotional distress is more likely in chaotic or unsafe environments. Responsible use includes preparing mentally and physically beforehand.

• Not Suitable for Mental Health Conditions
  Individuals with a history of schizophrenia, bipolar disorder, or extreme anxiety should avoid 1P-LSD due to the risk of psychological destabilization.

• Interactions with Other Drugs
  Combining 1P-LSD with alcohol, stimulants, or psychiatric medications can increase risks and alter the experience unpredictably.

• Safe Handling Guidelines
  Users should avoid driving, operating machinery, or making important decisions under the influence. Set and setting are critical to ensuring a positive outcome.

• Long-Term Safety Unknown
  While short-term safety is established, there is limited data on chronic or high-frequency use over time. Caution and moderation are advised.

In most cases, 1P-LSD and its metabolites are not detected in standard workplace or law enforcement drug screens. However, advanced forensic tests and some specialized screenings may identify its presence. Because it converts into LSD, testing for LSD metabolites may occasionally detect 1P-LSD use indirectly.

• Standard Tests (5-panel, 10-panel)
  These tests typically do not check for LSD or lysergamides at all. As such, 1P-LSD use will not trigger a positive result in routine screenings.

• Specialized LSD Panels
  Some extended panels used in clinical or forensic settings include LSD testing. Because 1P-LSD metabolizes into LSD, it may show up as a positive LSD result in these cases.

• Detection Window
  1P-LSD is cleared relatively quickly. Metabolites may remain detectable for 24 to 72 hours, depending on dose and individual metabolism.

• Urine Testing
  While LSD and 1P-LSD can sometimes be detected in urine via advanced testing, this is rare and usually only pursued in legal or medical investigations.

• Blood Testing
  Blood tests may reveal active compounds shortly after ingestion, but these are expensive and time-sensitive, limiting their use.

• Hair Follicle Tests
  These tests can detect LSD analogs for up to 90 days but are almost never used outside of law enforcement or research.

• False Positives Unlikely
  1P-LSD does not mimic the metabolites of other common drugs like amphetamines or benzodiazepines, so it won’t cause cross-reactivity in generic drug tests.

Proper storage of 1P-LSD is essential for preserving its potency and chemical integrity. Like LSD, 1P-LSD is sensitive to heat, light, oxygen, and moisture. Whether in tab, liquid, or powder form, storing it under the right conditions will prevent degradation and ensure long-term viability.

• Cool and Dark Environment
  Store 1P-LSD away from direct sunlight or warm areas. A dark drawer or sealed box is sufficient for short-term storage.

• Refrigeration (Preferred)
  Keeping 1P-LSD in a refrigerator extends its shelf life significantly. Use an airtight container or bag to prevent condensation and temperature fluctuations.

• Freezing for Long-Term Storage
  For storage beyond one year, especially for powder or tabs, freezing in vacuum-sealed bags or desiccant-lined containers is ideal.

• Avoid Humidity
  Moisture can destroy the compound, especially in paper blotters. Use silica packets in storage containers to absorb residual humidity.

• Use Amber Bottles for Liquid
  Light-sensitive solutions should be stored in dark glass vials to minimize UV degradation. Always seal tightly after each use.

• Separate from Strong Odors
  Store away from volatile compounds or strong-smelling substances. Some materials may interact chemically over time.

• Label with Date and Dose
  Always label containers with dosage concentration and packaging date to track potency and avoid confusion.

Yes, 1P-LSD, like other serotonergic psychedelics, builds rapid tolerance with repeated use. This means that the same dose will become less effective if taken within short intervals. Tolerance is primarily pharmacological, not psychological or emotional, and usually resets with adequate time between doses. Understanding how tolerance develops and how to manage it is key for responsible and effective use.

• Tolerance Builds After One Use
  After a single standard dose of 1P-LSD, the body begins to downregulate serotonin receptors, especially 5-HT2A, resulting in noticeably reduced sensitivity to further doses taken in the following days.

• Cross-Tolerance with Other Psychedelics
  Tolerance to 1P-LSD also applies to other psychedelics like LSD-25, psilocybin, and mescaline. If you take one substance, you’ll be less sensitive to the others for a few days.

• Reset Period: 3–7 Days
  Most users need to wait at least 3 to 5 days between doses to regain full sensitivity. A week is optimal to completely reset the tolerance threshold.

• High Tolerance Doesn’t Prevent Overwhelm
  While physical tolerance rises quickly, mental or emotional capacity may not. High doses taken too soon can still cause overwhelming psychological effects.

• No Long-Term Accumulation
  There’s no evidence that tolerance accumulates permanently with spaced use. However, frequent use without breaks can reduce the depth of the experience over time.

• Microdosing Tolerance
  Even with microdosing (5–15µg), users report diminished benefits after several consecutive weeks. Cycling (e.g., 4 weeks on, 2 weeks off) helps sustain efficacy.

Mixing 1P-LSD with other substances can significantly alter its effects, sometimes in unpredictable or dangerous ways. While some combinations are commonly used to enhance or modulate the experience, others can introduce serious physical or psychological risks. Caution and research are essential before mixing 1P-LSD with anything else.

• Cannabis (THC)
  Combining cannabis with 1P-LSD can intensify visuals and deepen introspection but may also increase anxiety, paranoia, or disorientation, especially for novice users.

• Alcohol
  Mixing with alcohol is not recommended. Alcohol can dull the psychedelic experience or impair judgment, increasing the risk of accidents or emotional volatility.

• Benzodiazepines (e.g., Xanax, Valium)
  These substances can suppress the psychedelic effects and are often used to abort or ease a bad trip. However, they come with their own risks and potential for dependency.

• SSRIs and Antidepressants
  Many SSRIs (Selective Serotonin Reuptake Inhibitors) reduce or block the effects of 1P-LSD. In rare cases, combining them can increase the risk of serotonin syndrome, a potentially life-threatening condition.

• MAOIs (Monoamine Oxidase Inhibitors)
  Mixing with MAOIs can dangerously intensify 1P-LSD’s effects, leading to overstimulation, confusion, or panic. This combination should be avoided unless under expert supervision.

• MDMA or Stimulants
  Stimulants can increase heart rate and blood pressure, compounding the physical stress of a psychedelic trip. Combining with MDMA (known as “candyflipping”) is popular but unpredictable and should only be done with experience and caution.

• Nootropics or Cognitive Enhancers
  Some users report synergy with compounds like L-theanine, magnesium, or racetams to smooth or sharpen the experience. While generally lower-risk, effects vary between individuals.

Both 1P-LSD and 1cP-LSD are lysergamide analogs of LSD-25 and act as prodrugs—they convert into LSD in the body. While their effects are very similar, there are subtle differences in their chemistry, legal status, and user reports. These compounds are often chosen based on availability or personal preference rather than major experiential differences.

• Chemical Structure
  1P-LSD includes a propionyl group, while 1cP-LSD contains a cyclopropanecarbonyl group. These are minor structural modifications but distinct enough for legal and research classification.

• Onset and Duration
  1cP-LSD may have a slightly faster onset (30–60 minutes) compared to 1P-LSD (45–90 minutes). Duration of effects is generally similar for both compounds.

• Subjective Effects
  Some users find 1P-LSD to be slightly “clearer” and more mentally stimulating, while 1cP-LSD is described as having a more relaxed body load. However, these differences are subtle and inconsistent.

• Potency
  Both substances are equally potent by weight, typically active at 100µg doses. Any variation in intensity is more likely due to individual body chemistry than the compound itself.

• Legality and Availability
  In some jurisdictions, 1P-LSD remains legal while 1cP-LSD has been specifically banned. Other regions are the reverse. Availability often determines preference.

• Research Use
  Both are commonly used in laboratory settings and by hobbyist researchers for non-clinical studies into consciousness and cognition.

1P-LSD is not currently approved for medical or therapeutic use, but it is often used in unregulated personal research and observational studies. Its structural similarity to LSD-25 makes it a surrogate for understanding the therapeutic potential of classic psychedelics, especially where LSD is legally restricted.

• Not Clinically Approved
  No government health agencies have approved 1P-LSD for formal therapeutic use. It is considered a research chemical with no established medical applications.

• Used in Observational Research
  Independent researchers and underground therapists sometimes use 1P-LSD to explore its efficacy in promoting emotional insight, PTSD processing, and neuroplasticity.

• Alternative to LSD in Restricted Jurisdictions
  In places where LSD is a Schedule I drug, 1P-LSD serves as a legal alternative for private therapeutic sessions or cognitive experimentation.

• Similar Mechanism to LSD
  Because 1P-LSD acts on the same 5-HT2A receptors, it shares the same psychological depth and introspective intensity that make psychedelics valuable in therapeutic settings.

• Potential for Emotional Breakthroughs
  Anecdotal reports describe 1P-LSD aiding in the resolution of past trauma, self-forgiveness, and deep emotional processing—though without professional oversight, results are inconsistent.

• Ethical and Legal Risks
  Using 1P-LSD for therapy outside legal frameworks can carry serious legal consequences and ethical concerns, especially if guided by unlicensed individuals.

Although 1P-LSD is active in microgram quantities, it has no known lethal dose and is considered physically non-toxic. That said, taking excessive amounts can lead to extreme psychological distress, disorientation, and behavioral risks. Overdosing on 1P-LSD doesn’t mean physical poisoning—it means taking more than your mind can handle safely.

• Extremely Low Physical Toxicity
  1P-LSD does not damage organs, disrupt vital systems, or lead to physical collapse, even at high doses. It is one of the safest compounds pharmacologically.

• Psychological Overload
  Extremely high doses (e.g., 500–1000µg+) can cause terrifying thought loops, dissociation, ego death, or panic attacks that feel overwhelming and traumatic.

• Danger from Actions, Not Substance
  Most 1P-LSD-related emergencies arise from poor decision-making, risky behavior, or panic—such as walking into traffic or jumping from heights—not from toxicity.

• No Need for Medical Detox
  Unlike opioids or stimulants, 1P-LSD overdose does not require detoxification or emergency pharmacological intervention. Time, support, and calm are usually sufficient.

• Abort Techniques (e.g., Benzodiazepines)
  If someone is overwhelmed, benzodiazepines like diazepam or lorazepam can reduce the intensity of the experience. However, these should only be used with caution and awareness of interactions.

• Avoid Redosing
  Impulsive redosing during a trip is a common cause of overdosing. Effects come on slowly, and increasing the dose prematurely can push the trip far beyond safe boundaries.